Skip to content

Scholar Rock SRRK Free cash flow margin

Discontinued — last reported Q1 '22

Free cash flow margin at other companies

Biogen logo
BiogenBIIB
24.4%-0.4pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
39.1%+32.8pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
34.9%-15.2pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-76.8%
Arrowhead Research logo
Arrowhead ResearchARWR
1.8%+0.9pp
Cytokinetics logo
CytokineticsCYTK
-518.8%-223pp

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

Based on trailing twelve months.

The official record: Scholar Rock’s 10-Q, filed May 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's free cash flow margin?
Scholar Rock (SRRK) reported free cash flow margin of -309.1% in Q1 2022.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.